Todaro et al., 2021 - Google Patents
- ️Fri Jan 01 2021
Todaro et al., 2021
-
Document ID
- 15719268822879349568 Author
- Healy A Publication year
- 2021 Publication venue
- Drug Development and Industrial Pharmacy
External Links
Snippet
Objective The focus of this study was to investigate the possibility of producing ibuprofen- nicotinamide (IBU-NIC) and ibuprofen-isonicotinamide (IBU-INA) cocrystal-containing granules, using a one-step fluidized bed dryer granulation manufacturing process, and …
- 239000008187 granular material 0 title abstract description 100
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Passerini et al. | 2010 | Melt granulation of pharmaceutical powders: a comparison of high-shear mixer and fluidised bed processes |
| Charoenchaitrakool et al. | 2000 | Micronization by rapid expansion of supercritical solutions to enhance the dissolution rates of poorly water-soluble pharmaceuticals |
| Kaialy et al. | 2014 | An approach to engineer paracetamol crystals by antisolvent crystallization technique in presence of various additives for direct compression |
| Raimi-Abraham et al. | 2015 | Development and characterization of amorphous nanofiber drug dispersions prepared using pressurized gyration |
| Huang et al. | 2013 | Using spray-dried lactose monohydrate in wet granulation method for a low-dose oral formulation of a paliperidone derivative |
| Raval et al. | 2013 | Influence of polymers/excipients on development of agglomerated crystals of secnidazole by crystallo-co-agglomeration technique to improve processability |
| Chatterjee et al. | 2017 | Spherical crystallization: A technique use to reform solubility and flow property of active pharmaceutical ingredients |
| Patel et al. | 2019 | Functionality improvement of Nimesulide by eutectic formation with nicotinamide: Exploration using temperature-composition phase diagram |
| Rehder et al. | 2013 | High-shear granulation as a manufacturing method for cocrystal granules |
| Maddineni et al. | 2015 | Influence of process and formulation parameters on dissolution and stability characteristics of Kollidon® VA 64 hot-melt extrudates |
| Todaro et al. | 2021 | Development and characterization of ibuprofen co-crystals granules prepared via fluidized bed granulation in a one-step process–a design of experiment approach |
| Kaur et al. | 2019 | Role of lattice disorder in water-mediated dissociation of pharmaceutical cocrystal systems |
| Martin et al. | 2009 | Production of polymorphs of ibuprofen sodium by supercritical antisolvent (SAS) precipitation |
| Górniak et al. | 2013 | Thermal, spectroscopic, and dissolution studies of the simvastatin–acetylsalicylic acid mixtures |
| Yadav et al. | 2010 | SOLVENT DIFFUSION (ESD) TECHNIQUE. |
| Daravath et al. | 2015 | Formulation and pharmacokinetics of gelucire solid dispersions of flurbiprofen |
| Tres et al. | 2015 | Monitoring the dissolution mechanisms of amorphous bicalutamide solid dispersions via real-time raman mapping |
| Wei et al. | 2018 | Solidification of hesperidin nanosuspension by spray drying optimized by design of experiment (DoE) |
| Maghsoodi | 2011 | Effect of process variables on physicomechanical properties of the agglomerates obtained by spherical crystallization technique |
| Theil et al. | 2018 | Manufacturing amorphous solid dispersions with a tailored amount of crystallized API for biopharmaceutical testing |
| Li et al. | 2017 | Use of spray-dried dispersions in early pharmaceutical development: theoretical and practical challenges |
| Erdemir et al. | 2018 | Novel co-processing methodology to enable direct compression of a poorly compressible, highly water-soluble active pharmaceutical ingredient for controlled release |
| Rajendran et al. | 2021 | Co-crystals for generic pharmaceuticals: an outlook on solid oral dosage formulations |
| Maghsoodi et al. | 2011 | Evaluation of physico-mechanical properties of drug-excipients agglomerates obtained by crystallization |
| Gupta et al. | 2005 | Spray drying for generation of a ternary amorphous system of celecoxib, PVP, and meglumine |